Whey and Soy Protein Supplementation in Football Players
Comparison of the Effect of Whey and Soy Protein Supplementation on Muscle Damage Markers and Performance After a Speed Endurance Training Protocol in Football Players
1 other identifier
interventional
10
1 country
1
Brief Summary
In a constant effort to find ways to make a quicker recovery between demanding workouts and football matches, this study is the first to investigate the benefits of protein supplementation, and compares two types of proteins, an animal-derived (whey) and a plant-derived (soy) protein, after an exercise-induced muscle injury caused by a speed endurance training protocol. Soy protein could be a cheaper and more environment-friendly alternative for athletes involved in high-velocity strength training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2018
CompletedStudy Start
First participant enrolled
November 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2019
CompletedNovember 24, 2020
November 1, 2020
2 months
October 12, 2018
November 23, 2020
Conditions
Outcome Measures
Primary Outcomes (12)
Change in field activity during the speed-endurance production training (SEPT)
Field activity will be continuously recorded during both SEPT sessions using global positioning system (GPS) technology
Throughout the SEPT sessions in all trials
Change in heart rate during the speed-endurance production training (SEPT)
Heart rate will be continuously recorded during both SEPT sessions using heart rate monitors.
Throughout the SEPT sessions in all trials
Change in creatine kinase in plasma
Concentration of creatine kinase will be measured in plasma
Baseline; Post-loading (Day 7); 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in repeated sprint ability (RSA)
5 x 30 m sprints will be performed with 25 seconds rest in-between
Baseline; Post-loading (Day 7); 24 hours (Day 9) following SEPT session 1
Change in countermovement jump (jump height in centimeters)
Countermovement jump will be assessed on a contact platform
Baseline; Post-loading (Day 7); 24 hours (Day 9) following SEPT session 1
Change in isokinetic strength of lower limbs
Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 60 degrees.
Baseline; Post-loading (Day 7); 24 hours (Day 9) following SEPT session 1
Change in maximal voluntary isometric contraction (MVIC) of lower limbs
MVIC will be assessed on an isokinetic dynamometer for knee extensors at 90 degrees and knee flexors at 30 degrees
Baseline; Post-loading (Day 7); 1, 2 and 3 hours post-SEPT session 1; 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in delayed onset of muscle soreness
Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10). A score of O indicates no sign or symptom of DOMS, a score of 10 indicated severe signs and symptoms of delayed onset muscle soreness (DOMS). These signs and symptoms include dull, diffuse pain and tenderness; stiffness; swelling; and decreased strength of the exercised muscle.
Baseline; Post-loading (Day 7); 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in total antioxidant capacity in plasma
Total antioxidant capacity will be measured in plasma
Baseline; Post-loading (Day 7); 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in protein carbonyl levels in plasma
Protein carbonyl levels will be measured in plasma
Baseline; Post-loading (Day 7); 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in GSH levels in red blood cell lysate
GSH will be measured in red blood cell lysate
Baseline; Post-loading (Day 7); 24 hours (Day 9) and 48 hours (Day 10) following SEPT session 1.
Change in sprint time
Sprint time will be assessed over a 10m and 30m distance using light cells.
Baseline; Post-loading (Day 7); 24 hours (Day 9) following SEPT session 1
Secondary Outcomes (7)
Dietary intake
Over a 7-day period at baseline.
Concentration of blood lactate
Pre- and Post-SEPT session 1 (Day 8), Pre- and Post-SEPT session 2 (Day 10)
Change in habitual physical activity
Over a 7-day period at baseline
Change in resting metabolic rate (RMR)
At baseline.
Change in body composition
At baseline.
- +2 more secondary outcomes
Study Arms (3)
Whey protein
EXPERIMENTALWhey protein isolate supplementation (7 day pre-loading phase and 3 day training phase). The protein dose will be individually adjusted to reach a total protein intake of 1.5 g protein/kg body mass/day.
Soy protein
EXPERIMENTALSoy protein isolate supplementation (7 day pre-loading phase and 3 day training phase). The protein dose will be individually adjusted to reach a total protein intake of 1.5 g protein/kg body mass/day.
Placebo (maltodextrin)
PLACEBO COMPARATORIsoenergetic, maltodextrin (7 day pre-loading phase and 3 day training phase)
Interventions
Whey protein isolate supplementation, individually adjusted to reach a total protein intake of 1.5 g/kg body weight/day for 10 days (7 days pre-loading and 3 days during trials 1 and 2)
Soy protein isolate supplementation, individually adjusted to reach a total protein intake of 1.5 g/kg body weight/day for 10 days (7 days pre-loading and 3 days during trials 1 and 2)
Isoenergetic placebo (maltodextrin) for 10 days (7 days pre-loading and 3 days during trials 1 and 2
Eligibility Criteria
You may qualify if:
- Playing at a competitive level (top three divisions) for ≥3 years
- Free of any recent history of illnesses, musculoskeletal problems and metabolic diseases
- No use of supplements and medications (for ≤6 months prior to the study)
- Non-smokers
You may not qualify if:
- A known milk intolerance or allergy
- A recent febrile illness
- History of muscle lesion
- Lower limb trauma
- Metabolic diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly
Trikala, 42100, Greece
Related Publications (1)
Kritikos S, Papanikolaou K, Draganidis D, Poulios A, Georgakouli K, Tsimeas P, Tzatzakis T, Batsilas D, Batrakoulis A, Deli CK, Chatzinikolaou A, Mohr M, Jamurtas AZ, Fatouros IG. Effect of whey vs. soy protein supplementation on recovery kinetics following speed endurance training in competitive male soccer players: a randomized controlled trial. J Int Soc Sports Nutr. 2021 Mar 16;18(1):23. doi: 10.1186/s12970-021-00420-w.
PMID: 33726784DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Savvas Kritikos, MScc
UNIVERSITY OF THESSALY, SCHOOL OF PHYSICAL EDUCATION & SPORTS SCIENCES
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 12, 2018
First Posted
November 26, 2018
Study Start
November 8, 2018
Primary Completion
January 20, 2019
Study Completion
February 20, 2019
Last Updated
November 24, 2020
Record last verified: 2020-11